ArticleEmerging microbes & infections2021

A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters.

Bao-Zhong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.